Jennifer Sears
Family · Manchester, TNNPI 1245480193
Payments from drug & device makers
Across 207 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$793
- AbbVie$676
- Astellas Pharma US Inc$282
- Pfizer$225
- Lilly USA, LLC$206
- Novartis$106
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,320100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $793 |
| AbbVie | 42 | $676 |
| Astellas Pharma US Inc | 16 | $282 |
| Pfizer | 14 | $225 |
| Lilly USA, LLC | 12 | $206 |
| Novartis | 6 | $106 |
| Bayer | 5 | $106 |
| AstraZeneca | 7 | $105 |
| Jazz Pharmaceuticals Inc. | 4 | $90 |
| Amgen | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 5 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $73 |
| Boehringer Ingelheim | 4 | $64 |
| Merck | 4 | $58 |
| Dexcom, Inc. | 3 | $55 |
| Abbott | 3 | $43 |
| Corcept Therapeutics | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Amarin Pharma, Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $24 |
| Gilead | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| GSK | 1 | $12 |
| Sumitomo Pharma America, Inc. | 1 | $10 |
How this compares
$3,320 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $80,919 |
| MounjaroTirzepatide | 48 | $66,130 |
| FarxigaDapagliflozin Propanediol | 81 | $59,953 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 52 | $45,868 |
| EliquisApixaban | 48 | $42,492 |
| JardianceEmpagliflozin | 39 | $34,909 |
| XareltoRivaroxaban | 24 | $31,410 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $30,263 |
| TradjentaLinagliptin | 20 | $28,282 |
| RybelsusSemaglutide | 12 | $25,456 |
| UbrelvyUbrogepant | 24 | $25,258 |
| LinzessLinaclotide | 42 | $24,404 |
| VraylarCariprazine Hcl | 26 | $21,456 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 29 | $20,433 |
| QuliptaAtogepant | 18 | $18,448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $105 | $109,390146 claims |
| Novo NordiskOzempic, Rybelsus | $793 | $106,37590 claims |
| AbbVieUbrelvy, Linzess, Vraylar, Qulipta, Synthroid | $676 | $92,285157 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $64 | $83,62488 claims |
| Lilly USA, LLCMounjaro, Trulicity | $206 | $80,37959 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $12 | $46,15272 claims |
| PfizerEliquis | $225 | $42,49248 claims |
| NovartisEntresto | $106 | $8,88612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Manchester
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.